Curated News
By: NewsRamp Editorial Staff
October 18, 2024
Oragenics to Present at Centurion One Capital 2nd Annual Bahamas Summit
Discuss on Reddit
LinkedIn
GithubTLDR
- Oragenics (NYSE American: OGEN) will present at the Centurion One Capital 2nd Annual Bahamas Summit, offering unique insights for competitive advantage.
- President Michael Redmond of Oragenics will deliver a corporate presentation at 1:20 p.m. ET on Oct. 22 at the Rosewood Baha Mar Hotel in Nassau, Bahamas.
- Oragenics focuses on brain-related health treatments, aiming to improve neurological conditions and combat infectious diseases for a better tomorrow.
- Join Oragenics at the Centurion One Capital 2nd Annual Bahamas Summit for an exciting glimpse into brain health innovations and medical advancements.
Impact - Why it Matters
This news matters because it highlights Oragenics' participation in a significant event focusing on brain-related health treatments and infectious diseases. The company's presentation at the summit showcases its commitment to innovation and potential advancements in the field of neurology and pharmaceuticals.
Summary
Oragenics (NYSE American: OGEN), a company specializing in brain-related health treatments, will present at the Centurion One Capital 2nd Annual Bahamas Summit on Oct. 22-23, 2024. President Michael Redmond will deliver a corporate presentation and participate in a Q&A session at 1:20 p.m. ET on Oct. 22 at the Rosewood Baha Mar Hotel in Nassau, Bahamas. Oragenics focuses on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (“mTBI”) and Niemann Pick Disease Type C (“NPC”). For more information, visit the company’s website at www.Oragenics.com.
Source Statement
This curated news summary relied on this press release disributed by InvestorBrandNetwork (IBN). Read the source press release here, Oragenics to Present at Centurion One Capital 2nd Annual Bahamas Summit
